Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU
Placebo? no thanks, it might be bad for me!
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
On dihydroorotate dehydrogenases, their inhibitors and uses.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis.
Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.
Reproductive issues in women with multiple sclerosis: ethical considerations.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
How Natalizumab Binds and Antagonizes α4 Integrins.
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Cytokines and Disability in Interferon-β-1b Treated and Untreated Women with Multiple Sclerosis.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
Disease-modifying therapies in Chinese children with multiple sclerosis.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod

Pages